Skip Navigation

QJM 2007 100(5):312-313; doi:10.1093/qjmed/hcm027
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Seet, R.C.S.
Right arrow Articles by Lim, E.C.H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Seet, R.C.S.
Right arrow Articles by Lim, E.C.H.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2007. Published by Oxford University Press on behalf of the Association of Physicians. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

Complications arising from intravenous buprenorphine abuse

The first 10% of the full text of this article appears below.

Sir,

Following its introduction in the 1980s, buprenorphine (Subutex, Schering Plough) abuse has been reported worldwide.1,2 Within a year of its introduction to treat opioid dependence in Singapore in 2002, buprenorphine became the . . . [Full Text of this Article]

R.C.S. Seet, V.M.S. Oh and E.C.H. Lim

Department of Medicine
National University Hospital
Singapore

email: raymond_seet@nus.edu.sg


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?